Martín A. Rivas

2.8k citations

27 papers · 1.6k indexed · 1 hit paper · h-index 17

Oncology top 5%
Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 5%
Cancer Research top 5%
Immunology top 10%

Co-authors: Patricia V. Elizalde Roxana Schillaci Wendy Béguelin Cecilia J. Proietti Cinthia Rosemblit Eduardo H. Charreau Leandro Venturutti Mercedes Tkach
Topics: Cytokine Signaling Pathways and Interactions (10 papers)Genomics and Chromatin Dynamics (6 papers)HER2/EGFR in Cancer Research (5 papers)
Cited by: Oncology Cancer Research Genetics
Journals: Nature Communications The Journal of Experimental MedicineSHILAP Revista de lepidopterología
Partner nations: Argentina United States Israel

In The Last Decade

Martín A. Rivas

27 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

2016 511 citations María Teresa Herrera-Abreu, Marta Palafox et al. Cancer Research profile →

Peers

Countries citing papers authored by Martín A. Rivas

Since Specialization

Citations

This map shows the geographic impact of Martín A. Rivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martín A. Rivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martín A. Rivas more than expected).

Fields of papers citing papers by Martín A. Rivas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martín A. Rivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martín A. Rivas. The network helps show where Martín A. Rivas may publish in the future.

Co-authorship network of co-authors of Martín A. Rivas

This figure shows the co-authorship network connecting the top 25 collaborators of Martín A. Rivas. A scholar is included among the top collaborators of Martín A. Rivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martín A. Rivas. Martín A. Rivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ras-transfected human mammary tumour cells are resistant to photodynamic therapy by mechanisms related to cell adhesion 2022 ·Life Sciences ·Lorena Rodríguez,Gabriela Di Venosa,Martín A. Rivas,Ángeles Juarranz,Francisco Sanz‐Rodríguez,Adriana Casas	2
2	Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes 2021 ·Frontiers in Immunology ·Martín A. Rivas,Ceyda Durmaz,Andreas Kloetgen,(unknown),Zhengming Chen,Bhavneet Bhinder,Amnon Koren,Aaron D. Viny,Christopher D. Scharer,Jeremy M. Boss,Olivier Elemento,Christopher E. Mason,Ari Melnick	6
3	OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity 2021 ·Nature Immunology ·Ashley S. Doane,Chi-Shuen Chu,Dafne Campigli Di Giammartino,Martín A. Rivas,Johannes C. Hellmuth,Yanwen Jiang,Nevin Yusufova,Alicia Alonso,Robert G. Roeder,Effie Apostolou,Ari Melnick,Olivier Elemento	10
4	Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response 2020 ·Cancer Cell ·Wendy Béguelin,Matt Teater,Cem Meydan,Kenneth B. Hoehn,Jude M. Phillip,Alexey A. Soshnev,Leandro Venturutti,Martín A. Rivas,María Teresa Calvo,Johana Gutierrez,Jeannie M. Camarillo,Katsuyoshi Takata,Karin Tarte,Neil L. Kelleher,Christian Steidl,Christopher E. Mason,Olivier Elemento,C. David Allis,Steven H. Kleinstein,Ari Melnick	83
5	Role of chromosomal architecture in germinal center B cells and lymphomagenesis 2019 ·Current Opinion in Hematology ·Martín A. Rivas,Ari Melnick	6
6	EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop 2017 ·Nature Communications ·Wendy Béguelin,Martín A. Rivas,María Teresa Calvo,Matt Teater,Alberto Purwada,David Redmond,Hao Shen,(unknown),Olivier Elemento,Ankur Singh,Ari Melnick	129
7	Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancerbreakdown → 2016 ·Cancer Research ·María Teresa Herrera-Abreu,Marta Palafox,Uzma Asghar,Martín A. Rivas,Rosalind Cutts,Isaac García-Murillas,Alex Pearson,Marta Guzmán,Olga Rodríguez,Judit Grueso,Meritxell Bellet,Javier Cortés,Richard Elliott,Sunil Pancholi,Christopher J. Lord,José Baselga,Mitch Dowsett,Lesley‐Ann Martin,Nicholas C. Turner,Violeta Serra	511
8	TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer 2016 ·Clinical Cancer Research ·María F. Mercogliano,Mara De Martino,Leandro Venturutti,Martín A. Rivas,Cecilia J. Proietti,Gloria Inurrigarro,Isabel Frahm,(unknown),Ernesto Gil Deza,(unknown),Felipe G. Gercovich,Pablo Guzmán,Juan Carlos Roa,Patricia V. Elizalde,Roxana Schillaci	81
9	MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 2016 ·Oncogene ·Leandro Venturutti,Rosalía I. Cordo Russo,Martín A. Rivas,María F. Mercogliano,Franco Izzo,Robert H. Oakley,(unknown),Mara De Martino,Cecilia J. Proietti,Patricio Yankilevich,Juan Carlos Roa,Pablo Guzmán,(unknown),(unknown),Tzu-Hsuan Huang,(unknown),John A. Cidlowski,Roxana Schillaci,Patricia V. Elizalde	74
10	EZH2 Enables the Proliferation of Germinal Center B Cells and DLBCL through a Rb-E2F1 Positive Feedback Loop Involving Repression of CDKN1A 2016 ·Blood ·Wendy Béguelin,Martín A. Rivas,María Teresa Calvo,Ari Melnick	1
11	p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth 2013 ·Endocrine Related Cancer ·Mercedes Tkach,Cinthia Rosemblit,Martín A. Rivas,Cecilia J. Proietti,María C. Díaz Flaqué,María F. Mercogliano,Wendy Béguelin,(unknown),Pablo Guzmán,Felipe G. Gercovich,Ernesto Gil Deza,Patricia V. Elizalde,Roxana Schillaci	77
12	Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development 2012 ·Breast Cancer Research ·Martín A. Rivas,Leandro Venturutti,Yi‐Wen Huang,Roxana Schillaci,Tim H.‐M. Huang,Patricia V. Elizalde	92
13	Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model 2012 ·PLoS ONE ·(unknown),Mercedes Tkach,Mariya I. Meschaninova,Martín A. Rivas,Patricia V. Elizalde,A. G. Venyaminova,Roxana Schillaci,Jean‐Christophe François	38
14	Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3 2010 ·Molecular and Cellular Biology ·Wendy Béguelin,María C. Díaz Flaqué,Cecilia J. Proietti,Florencia Cayrol,Martín A. Rivas,Mercedes Tkach,Cinthia Rosemblit,(unknown),Eduardo H. Charreau,Roxana Schillaci,Patricia V. Elizalde	85
15	Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer 2010 ·Steroids ·Cecilia J. Proietti,Wendy Béguelin,María C. Díaz Flaqué,Florencia Cayrol,Martín A. Rivas,Mercedes Tkach,Eduardo H. Charreau,Roxana Schillaci,Patricia V. Elizalde	23
16	Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation 2009 ·Breast Cancer Research and Treatment ·Martín A. Rivas,Mercedes Tkach,Wendy Béguelin,Cecilia J. Proietti,Cinthia Rosemblit,Eduardo H. Charreau,Patricia V. Elizalde,Roxana Schillaci	31
17	Stat3 enhances Progesterone Receptor (PR)-mediated transcriptional activity through Sp-1 in the p21 promoter in breast cancer cells. 2008 ·Cancer Research ·Cecilia J. Proietti,Cinthia Rosemblit,Wendy Béguelin,Victoria Sundblad,(unknown),Martín A. Rivas,Romina P. Carnevale,Eduardo H. Charreau,Roxana Schillaci,Patricia V. Elizalde	1
18	Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth 2008 ·Molecular and Cellular Biology ·Cecilia J. Proietti,Cinthia Rosemblit,Wendy Béguelin,Martín A. Rivas,María C. Díaz Flaqué,Eduardo H. Charreau,Roxana Schillaci,Patricia V. Elizalde	46
19	TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways 2007 ·Experimental Cell Research ·Martín A. Rivas,Romina P. Carnevale,Cecilia J. Proietti,Cinthia Rosemblit,Wendy Béguelin,Mariana Salatino,Eduardo H. Charreau,Isabel Frahm,Sandra Sapia,Peter Brouckaert,Patricia V. Elizalde,Roxana Schillaci	133
20	Immunization with Murine Breast Cancer Cells Treated with Antisense Oligodeoxynucleotides to Type I Insulin-Like Growth Factor Receptor Induced an Antitumoral Effect Mediated by a CD8+ Response Involving Fas/Fas Ligand Cytotoxic Pathway 2006 ·The Journal of Immunology ·Roxana Schillaci,Mariana Salatino,Juliana Cassataro,Cecilia J. Proietti,Guillermo H. Giambartolomei,Martín A. Rivas,Romina P. Carnevale,Eduardo H. Charreau,Patricia V. Elizalde	25

About Martín A. Rivas

Martín A. Rivas is a scholar working on Oncology, Cancer Research and Immunology, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (10 papers), Genomics and Chromatin Dynamics (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (845 citations), Cancer Research (397 citations) and Genetics (173 citations). Martín A. Rivas has collaborated with scholars based in Argentina, United States and Israel. Frequent co-authors include Patricia V. Elizalde, Roxana Schillaci, Wendy Béguelin, Cecilia J. Proietti, Cinthia Rosemblit, Eduardo H. Charreau, Leandro Venturutti, Mercedes Tkach, Ari Melnick and Christopher J. Lord. Their work appears in journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact